MINERVA SURGICAL, INC. Financials Minerva Surgical, Inc.
Equities
UTRS
US60343F2056
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.001 USD | -99.76% |
|
-99.78% | -99.91% |
| Jan. 03 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from S&P TMI Index | CI |
| 2023 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from NASDAQ Composite Index | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 |
|---|---|---|
| Capitalization 1 | 148.1 | 6.58 |
| Enterprise Value (EV) 1 | 146.8 | 39.33 |
| P/E ratio | -1.68 x | -0.19 x |
| Yield | - | - |
| Capitalization / Revenue | 2.84 x | 0.13 x |
| EV / Revenue | 2.82 x | 0.78 x |
| EV / EBITDA | -8.11 x | -1.35 x |
| EV / FCF | -7,198,359 x | -2,691,966 x |
| FCF Yield | -0% | -0% |
| Price to Book | 3.36 x | 0.39 x |
| Nbr of stocks (in thousands) | 1,441 | 1,473 |
| Reference price 2 | 102.8 | 4.468 |
| Announcement Date | 3/23/22 | 3/22/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Net sales 1 | 26.01 | 37.77 | 52.1 | 50.29 |
| EBITDA 1 | -17.96 | -7.489 | -18.1 | -29.19 |
| EBIT 1 | -19.64 | -14.56 | -28.72 | -39.99 |
| Operating Margin | -75.49% | -38.56% | -55.12% | -79.52% |
| Earnings before Tax (EBT) 1 | -52.05 | -18.4 | -21.46 | -34.1 |
| Net income 1 | -52.05 | -18.26 | -21.46 | -34.11 |
| Net margin | -200.08% | -48.36% | -41.2% | -67.83% |
| EPS 2 | -1,155 | -378.3 | -61.22 | -23.68 |
| Free Cash Flow | - | -0.8456 | -20.39 | -14.61 |
| FCF margin | - | -2.24% | -39.14% | -29.05% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 9/27/21 | 9/27/21 | 3/23/22 | 3/22/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 12.51 | 13.64 | 10.94 | 12.97 | 12.59 | 13.8 | 12.53 | 13.39 | 11.96 |
| EBITDA 1 | -2.589 | -6.654 | -10.3 | -4.899 | -5.841 | -5.672 | -6.525 | -4.579 | -3.819 |
| EBIT 1 | -6.14 | -6.654 | -10.3 | -4.899 | -10.51 | -5.192 | -10.31 | -7.658 | -6.096 |
| Operating Margin | -49.1% | -48.77% | -94.19% | -37.78% | -83.48% | -37.61% | -82.26% | -57.19% | -50.95% |
| Earnings before Tax (EBT) 1 | -3.225 | 10.82 | -10.92 | -5.613 | -11.33 | -6.234 | -11.34 | -8.642 | -7.178 |
| Net income 1 | -3.225 | 10.81 | -10.92 | -5.613 | -11.33 | -6.234 | -11.34 | -8.681 | -7.181 |
| Net margin | -25.79% | 79.21% | -99.91% | -43.29% | -90% | -45.16% | -90.51% | -64.83% | -60.02% |
| EPS 2 | -2.240 | 7.500 | -7.600 | -4.000 | -8.000 | -4.000 | -2.400 | -1.000 | -0.8100 |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 12/2/21 | 3/8/22 | 5/11/22 | 8/9/22 | 11/14/22 | 3/22/23 | 5/2/23 | 8/2/23 | 11/13/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Net Debt 1 | 48.9 | 80 | - | 32.7 |
| Net Cash position 1 | - | - | 1.33 | - |
| Leverage (Debt/EBITDA) | -2.721 x | -10.68 x | - | -1.122 x |
| Free Cash Flow | - | -0.85 | -20.4 | -14.6 |
| ROE (net income / shareholders' equity) | - | 20% | 78.8% | -111% |
| ROA (Net income/ Total Assets) | - | -13.1% | -17.3% | -27.2% |
| Assets 1 | - | 139.2 | 123.9 | 125.5 |
| Book Value Per Share 2 | -4,539 | -3,720 | 30.60 | 11.50 |
| Cash Flow per Share 2 | 601.0 | 291.0 | 28.20 | 4.660 |
| Capex 1 | 0.22 | 0.45 | 0.58 | 0.07 |
| Capex / Sales | 0.86% | 1.2% | 1.12% | 0.15% |
| Announcement Date | 9/27/21 | 9/27/21 | 3/23/22 | 3/22/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -99.91% | 8.88K | |
| +12.07% | 128B | |
| -9.04% | 10.65B | |
| +0.91% | 8.82B | |
| +16.72% | 7.19B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B |
- Stock Market
- Equities
- UTRS Stock
- Financials Minerva Surgical, Inc.
